Western Wealth Management LLC Reduces Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Western Wealth Management LLC lowered its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 1.2% during the 4th quarter, HoldingsChannel reports. The fund owned 60,200 shares of the pharmacy operator’s stock after selling 752 shares during the period. Western Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $1,572,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the business. EverSource Wealth Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 308.4% during the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 845 shares during the last quarter. Highlander Capital Management LLC purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $26,000. Venturi Wealth Management LLC raised its holdings in shares of Walgreens Boots Alliance by 1,241.8% during the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 981 shares during the last quarter. FinTrust Capital Advisors LLC increased its holdings in Walgreens Boots Alliance by 2,314.5% during the third quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 1,273 shares during the last quarter. Finally, Rocky Mountain Advisers LLC purchased a new stake in Walgreens Boots Alliance during the fourth quarter valued at approximately $30,000. Institutional investors own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Leerink Partnrs reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research report on Wednesday, April 3rd. Morgan Stanley dropped their price target on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a research report on Monday, April 1st. TheStreet upgraded shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research report on Monday, January 8th. Finally, TD Cowen dropped their price target on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a research report on Wednesday, April 3rd. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $24.36.

Insider Buying and Selling at Walgreens Boots Alliance

In other news, Director Valerie B. Jarrett bought 4,456 shares of Walgreens Boots Alliance stock in a transaction dated Monday, January 29th. The shares were acquired at an average price of $22.44 per share, with a total value of $99,992.64. Following the completion of the purchase, the director now owns 4,456 shares in the company, valued at approximately $99,992.64. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, April 11th. The shares were bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Valerie B. Jarrett purchased 4,456 shares of Walgreens Boots Alliance stock in a transaction that occurred on Monday, January 29th. The stock was bought at an average cost of $22.44 per share, for a total transaction of $99,992.64. Following the purchase, the director now directly owns 4,456 shares in the company, valued at $99,992.64. The disclosure for this purchase can be found here. Insiders acquired 13,456 shares of company stock worth $270,423 over the last 90 days. 17.40% of the stock is owned by insiders.

Walgreens Boots Alliance Price Performance

WBA stock traded up $0.16 during trading on Friday, hitting $17.75. 1,496,123 shares of the company’s stock traded hands, compared to its average volume of 14,074,323. Walgreens Boots Alliance, Inc. has a 52 week low of $17.51 and a 52 week high of $36.14. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. The business has a fifty day simple moving average of $20.50 and a 200 day simple moving average of $21.95. The stock has a market capitalization of $15.31 billion, a price-to-earnings ratio of -2.52, a P/E/G ratio of 1.09 and a beta of 0.73.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. During the same quarter last year, the business earned $1.16 earnings per share. Walgreens Boots Alliance’s quarterly revenue was up 6.3% compared to the same quarter last year. As a group, research analysts expect that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.